At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.

Annual BioTech Breakthrough Award is devoted to honoring excellence in life science and biotechnology solutions, services, ...

Medically reviewed by Soma Mandal, MD High blood pressure (hypertension) can lead to serious complications like heart attack ...

The trials highlighted elinzanetant's positive impact on quality of life for women with severe VMS. Notable adverse events ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

primarily revolving around promising clinical trial results for Silence Therapeutics’ lead product candidate, zerlasiran. The recent data from the ALPACAR-360 phase II study presented at the American ...

A recent study published in the Journal of Medical Internet Research introduced the EDAI framework, a comprehensive guideline designed to embed equity, diversity, and inclusion (EDI) principles ...